IP Library Granted Patent US 12692519
Granted Patent B2
US 12692519 · App. 17/768,228 · Granted Jul 28, 2026

Engineered autotrophic bacteria for CO

Inventors: Ron Milo (Kfar-Saba, IL); Shmuel Gleizer (Rehovot, IL); Niv Antonovsky (Rehovot, IL); Elad Noor (Rehovot, IL); Arren Bar-Even (Rehovot, IL); Yehudit Zohar (Rehovot, IL); Roee Ben Nissan (Rehovot, IL); Elad Herz (Rehovot, IL); Yinon Moise Bar-On (Rehovot, IL)
Assignee: Yeda Research and Development Co. Ltd.
C12P1/04C07K14/195C12N1/20C12N9/0008C12N9/1205C12N9/88C12Y102/02001C12Y207/01019C12Y401/01039C12Y402/01001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12692519
App. No.
17/768,228
Granted
Jul 28, 2026
Kind
B2
Abstract

A recombinant bacteria which is genetically modified to express formate dehydrogenase (FDH), phosphoribulokinase (prk) and Ribulose-Bisphosphate Carboxylase/oxygenase (RuBisCo) is disclosed. The bacteria may be modified to be autotrophic.

Claims (16)

1 . A population of recombinant bacteria which is genetically modified to express formate dehydrogenase (FDH), phosphoribulokinase (prk) and Ribulose-Bisphosphate Carboxylase/oxygenase (RuBisCo), wherein the recombinant bacteria is E. Coli , wherein the bacteria is capable of autotrophic growth following a culturing protocol which comprises:

(a) culturing said bacteria in a medium comprising a pentose or hexose sugar;

and subsequently

(b) reducing the amount of said pentose or hexose sugar in said medium and increasing the amount of formate in said medium.

2 . The population of recombinant bacteria of claim 1 , being further genetically modified to express carbonic anhydrase (CA).

3 . The population of recombinant bacteria of claim 1 , wherein said bacteria is modified so as to delete 6-phosphate-1-dehydrogenase (zwf), phosphofructokinase A (pfkA) and phosphofructokinase B (pfkB).

4 . The population of recombinant bacteria of claim 1 ,

(a) wherein glucosephosphate isomerase (pgi) of said bacteria comprises a H386Y mutation;

(b) wherein phosphoribosylpyrophosphate synthase (prs) of said bacteria comprises a I171T mutation;

(c) wherein uridylate kinase (pyrH) of the bacteria comprises a I133M mutation; and/or

(d) wherein 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (aroH) of said bacteria comprises D109N mutation.

5 . The population of recombinant bacteria of claim 1 , having a D866E mutation in RNA polymerase, beta subunit (rpoB).

6 . The population of recombinant bacteria of claim 1 , being an autotroph.

7 . The population of recombinant bacteria of claim 1 , wherein the bacteria is not, in its native state, capable of biosynthesizing metabolites by utilizing CO 2 as a sole carbon source.

8 . A cell culture comprising a medium and the population of recombinant bacteria of claim 1 , wherein said medium comprises formate.

9 . The cell culture of claim 8 , being devoid of an additional organic carbon source.